Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Neurosurgery · Sun Yat-sen University Cancer Center · Guangzhou

Dr. Chen Zhongping陈忠平

Chief Physician · Professor
Department head

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Chen Zhongping

Professional overview

Chen Zhongping is a Chief Physician and Professor in the Department of Neurosurgery at Sun Yat-sen University Cancer Center, specializing in microsurgical resection and comprehensive treatment of nervous system tumors, particularly gliomas.

SpecialtyNeurosurgery
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor
DepartmentDepartment of Neurosurgery
HospitalSun Yat-sen University Cancer Center
CityGuangzhou
Hospital roleFounding Director of the Department of Neurosurgery

Department leadership

Department head

A department head is an organisational role. “Chief Physician” is a clinical rank; the two are listed separately.

Areas of focus

GliomaSpecializes in microsurgical resection and comprehensive treatment of gliomas.

Background

  • 1982Graduated with a bachelor's degree from Suzhou Medical College.
  • 1989Earned a master's degree in neurosurgery.
  • 1993Earned a doctoral degree in neurosurgery; received WHO Third Prize for Chinese Young Professional in Mental Health & Neuroscience.
  • 1993Completed a postdoctoral fellowship in neurosurgery at McGill University, Canada.
  • 1996Served as Research Associate in neurosurgery and oncology at McGill University, Canada.
  • 1998Appointed Professor in neurosurgery and neuro-oncology at Sun Yat-sen University Cancer Center.
  • 1999Returned to China and established the Department of Neurosurgery at Sun Yat-sen University Cancer Center, serving as Director.

Experience & recognition

  • Performed over 5,000 microsurgical operations for nervous system tumors.
  • Managed comprehensive treatment for over 10,000 glioma patients.
  • First to report vasculogenic mimicry in human glioblastoma (2004).
  • Identified ERCC2 gene expression as associated with alkylating agent resistance in human tumors.
  • Demonstrated MGMT gene expression affects response to chloroethylnitrosourea chemotherapy in gliomas.
  • Discovered SarCNU’s efficacy against MGMT-positive resistant gliomas, linked to EMT transporter expression.
  • Recipient of the 2006 Wang Zhongcheng Annual Award for Neurosurgery (Academic Category).
  • Published over 200 academic papers, including more than 70 indexed by SCI.

Professional roles

  • Chair, Neuro-Oncology Society of China Anti-Cancer Association (CACA)
  • Former Chair, Guangdong/Guangzhou Anti-Cancer Association Neuro-Oncology Society
  • Former Vice Chair, Fifth Guangdong Neurosurgical Society
  • Editor-in-Chief, Glioma
  • Editorial Board Member, Neuro-Oncology
  • Editorial Board Member, Journal of Neuro-Oncology
  • Editorial Board Member, Neuro-Oncology Practice
  • Expert, National Natural Science Foundation of China (NSFC) Review Panel

Frequently asked questions

What does Dr. Chen Zhongping specialize in?

Microsurgical resection and comprehensive treatment of nervous system tumors, especially gliomas.

Which hospital and department is Dr. Chen Zhongping in?

Department of Neurosurgery at Sun Yat-sen University Cancer Center

Sources

Dr. Chen Zhongping has not reviewed this page.